Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation.

Kawaguchi H

Open source

DOI
10.1080/14712598.2026.2710868
Published
2026 Aug
Container
Expert opinion on biological therapy
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14712598.2026.2710868,
  title = {Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation.},
  author = {Kawaguchi H},
  year = {2026},
  journal = {Expert opinion on biological therapy},
  doi = {10.1080/14712598.2026.2710868},
  url = {https://doi.org/10.1080/14712598.2026.2710868}
}

RIS

TY  - JOUR
TI  - Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation.
AU  - Kawaguchi H
PY  - 2026
JO  - Expert opinion on biological therapy
DO  - 10.1080/14712598.2026.2710868
UR  - https://doi.org/10.1080/14712598.2026.2710868
ER  - 

APA

H, K. (2026). Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation.. Expert opinion on biological therapy. https://doi.org/10.1080/14712598.2026.2710868

Source records